ESPE Abstracts

ESPE Abstracts

Published by BioScientifica
Previous issue | Volume 86 | ESPE2016 | Next issue

55th Annual ESPE (ESPE 2016)

Paris, France
10 Sept 2016 - 12 Sept 2016

Card image cap
Paris, France: 10-12 September 2016 Further information

Poster Presentations

Bone & Mineral Metabolism P1

Previous section
Adrenal P2
Table of contents
Next section
Bone & Mineral Metabolism P2

hrp0086p1-p98 | Bone & Mineral Metabolism P1

Knock in of the Recurrent R368X Mutation of PRKAR1A that Represses cAMP-dependent Protein Kinase A Activation: A Model of Acrodysostosis Type 1?

hrp0086p1-p99 | Bone & Mineral Metabolism P1

Automated Greulich-Pyle Bone Age Determinations in Children with Chronic Endocrine Diseases

hrp0086p1-p100 | Bone & Mineral Metabolism P1

Cord 25-Hydroxyvitamin D and Infant Cranial Growth: An Odense Child Cohort Study

hrp0086p1-p101 | Bone & Mineral Metabolism P1

Effect of Bisphosphonates on Bone Fragility Due to Chronic Liver Disease in Ten Children

hrp0086p1-p102 | Bone & Mineral Metabolism P1

Radiologically Confirmed Fractures in a Scottish Nationwide Cohort of Boys with Duchenne Muscular Dystrophy

hrp0086p1-p103 | Bone & Mineral Metabolism P1

Monostotic Fibrous Dysplasia is a Single Disorder Caused by Somatic Mosaic Activating Mutations in GNAS

hrp0086p1-p104 | Bone & Mineral Metabolism P1

Clinically Significant Fracture Incidence in Czech Children: A Population-based Study

hrp0086p1-p105 | Bone & Mineral Metabolism P1

Effects of Selective GPER-1 Agonist G1 on Bone Growth

hrp0086p1-p106 | Bone & Mineral Metabolism P1

Bone Mineral Density, Pubertal Status and Ability to Walk are Associated to Fracture Incidence in Patients with Rett Syndrome

hrp0086p1-p107 | Bone & Mineral Metabolism P1

Bone Mineral Status in Children and Adolescents with Klinefelter Syndrome

hrp0086p1-p108 | Bone & Mineral Metabolism P1

Tolerability and Feasibility of Whole Body Vibration and its Effects on Muscle Function and Bone Health in Patients with Dystrophinopathy

hrp0086p1-p109 | Bone & Mineral Metabolism P1

Nonsense Mutation in SPARC Gene Causing Autosomal Recessive Ostegenesis Imperfecta

hrp0086p1-p110 | Bone & Mineral Metabolism P1

Increase in Sclerostin After Rapid Weight Loss in Children

hrp0086p1-p111 | Bone & Mineral Metabolism P1

Impact of Conventional Medical Treatment on Bone Mineral Density and Bone Turnover in Adult XLH Patients: A 6 Year Cohort Study

hrp0086p1-p112 | Bone & Mineral Metabolism P1

Bone Health and Body Composition in Childhood Onset Growth Hormone Deficiency at Time of Initial Evaluation and Retesting

hrp0086p1-p113 | Bone & Mineral Metabolism P1

Extension of The Bone Health Index to Adults, and Reference Curves of Four Indices of Cortical Bone for Healthy Europeans

hrp0086p1-p114 | Bone & Mineral Metabolism P1

Extension of Automated Bone Age Determination to the End of Puberty

hrp0086p1-p115 | Bone & Mineral Metabolism P1

A European Survey to Identify New Roads for Care, Training and Research Around Rare Metabolic Bone Diseases

hrp0086p1-p116 | Bone & Mineral Metabolism P1

Clinical and Molecular Characterization of 25-Hydroxylase Deficiency in Saudi Patients

hrp0086p1-p117 | Bone & Mineral Metabolism P1

No Severe Hypercalcemia During a 12-Month High-Dose Vitamin D Intervention in Infants

hrp0086p1-p118 | Bone & Mineral Metabolism P1

Management of Tracheobronchomalacia During Asfotase Alfa Treatment in Infants with Perinatal-onset Hypophosphatasia: A Case Series

hrp0086p1-p119 | Bone & Mineral Metabolism P1

Novel p.Asn628Ser Heterozygous Mutation in FGFR1 is Associated with Hartsfield Syndrome and Tumoral Calcinosis

hrp0086p1-p120 | Bone & Mineral Metabolism P1

Practicalities of Bisphosphonate use in UK Paediatric Tertiary Centres

hrp0086p1-p121 | Bone & Mineral Metabolism P1

Computer-assisted Diagnosis of Dyschondrosteosis Based on Skeletal X-ray Geometry

hrp0086p1-p122 | Bone & Mineral Metabolism P1

Bisphosphonates Therapy in Girls with Rett Syndrome and Bone Fragility

hrp0086p1-p123 | Bone & Mineral Metabolism P1

Skeletal Manifestations in APECED

hrp0086p1-p124 | Bone & Mineral Metabolism P1

Two French Families with Vitamin D Dependency Rickets Type 1B Harbor Homozygous Recessive Expression Of CYP2R1 Mutations L99P and G42_L46DEL INSR

hrp0086p1-p125 | Bone & Mineral Metabolism P1

Spectrum of the Genetic Defects in Hypophosphatemic Rickets in A Group of Turkish Children

hrp0086p1-p126 | Bone & Mineral Metabolism P1

Impact of Intercurrent Illness on Calcium Homeostasis and Hypoparathyroidism Management

hrp0086p1-p127 | Bone & Mineral Metabolism P1

Transient Pseudohypoaldosteronism and Failiure to Thrive in A 5-Month-Old Infant

hrp0086p1-p128 | Bone & Mineral Metabolism P1

Childhood Cancer Survivors (CCS) are at High Risk of Reduced Bone Mass During the Second Decade of Life

hrp0086p1-p129 | Bone & Mineral Metabolism P1

Trabecular Bone Score in Children from Mexico City: Preliminary Report

hrp0086p1-p130 | Bone & Mineral Metabolism P1

Triple X Syndrome: An Evaluation of Bone Mineral Status and Metabolism

hrp0086p1-p131 | Bone & Mineral Metabolism P1

Frequency of Recessive Osteogenesis Imperfecta in a Turkish Cohort and Genetic Causes

hrp0086p1-p132 | Bone & Mineral Metabolism P1

Spinal and Forearm Bone Mineralization in Adolescents with Klinefelter Syndrome

hrp0086p1-p133 | Bone & Mineral Metabolism P1

Treatment with Zoledronic Acid in Children with Duchenne Muscular Dystrophy

hrp0086p1-p134 | Bone & Mineral Metabolism P1

A RCT Comparing the Effect of Three Different Vitamin D Supplementation Regimens on Se 25 OH Vit D in Asymptomatic Vit D Deficient Children

hrp0086p1-p135 | Bone & Mineral Metabolism P1

Low Bone Mineral Density in Adolescents with Leukemia After Hematopoietic Stem Cell Transplantation

hrp0086p1-p136 | Bone & Mineral Metabolism P1

Growth Characteristics of a Girl with Multicentric Carpo-Tarsal Osteolysis Caused by Novel Mutation in the MAFB Gene

hrp0086p1-p137 | Bone & Mineral Metabolism P1

Treatment Experience and Long-Term Follow-Up Data in Two Severe Neonatal Hyperparathyroidism Cases

hrp0086p1-p138 | Bone & Mineral Metabolism P1

Biochemical Parameters Associated with Serum Intact FGF23 Levels in Patients with X-Linked Hypophosphatemic Rickets

hrp0086p1-p139 | Bone & Mineral Metabolism P1

Dental Effects of Intravenous Bisphosphonate When Administered in Early Infancy

hrp0086p1-p140 | Bone & Mineral Metabolism P1

Bone Mass and Vitamin D Status in Children and Adolescents with Generalized Epidermolysis Bullosa

hrp0086p1-p141 | Bone & Mineral Metabolism P1

Off-Label Use of the Aromatase Inhibitor Letrozole in Pubertal Boys to Improve Final Height: Laboratory, Auxological and Bone Age Data

hrp0086p1-p142 | Bone & Mineral Metabolism P1

Effect of Bisphosphonates and Denosumab on Trabecular Bone: Results of a Pilot Study in Children with Osteogenesis Imperfecta

hrp0086p1-p143 | Bone & Mineral Metabolism P1

Impact of Anti-Tumour Necrosis Factor Therapy on the Insulin Like Growth Factor Axis and Bone Development in Childhood Crohn’s Disease

hrp0086p1-p144 | Bone & Mineral Metabolism P1

Effects of Phylloquinone and Magnesium on ATDC5 Prechondrocytes

hrp0086p1-p145 | Bone & Mineral Metabolism P1

To Study the Efficacy and Safety of Growth Hormone (GH) Therapy in Children with Pycnodysostosis

Published by BioScientifica

ESPE Abstracts

© Bioscientifica 2025 | Privacy policy | Cookie settings

BiosciAbstracts

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more